A safe, localized treatment for chronic inflammation in the intestinal tract will move one step closer to helping patients reduce their risk of developing colon cancer, thanks to a three-year, $433,000 National Institutes of Health grant awarded to professor Hemachand Tummala.of the Department of Pharmaceutical Sciences.